Theseus Pharmaceuticals Stock Price, News & Analysis

THRX NASDAQ

Company Description

Theseus Pharmaceuticals (NASDAQ: THRX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

THRX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of THRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

44.6M

Shares outstanding

Theseus Pharmaceuticals (THRX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

February 14, 2024

0.00%

Theseus Pharmaceuticals Announces Closing of Tender Offer

January 30, 2024

+0.74%

Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals

December 22, 2023

+10.81%

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

acquisition

November 27, 2023

+4.97%

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

November 13, 2023

+50.00%

Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives

November 7, 2023

-3.49%

Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conference

conferences

Theseus Pharmaceuticals has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, conferences, earnings, clinical trial. View all THRX news →

SEC Filings

View All

No SEC filings available for THRX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

THRX Company Profile & Sector Positioning

Theseus Pharmaceuticals (THRX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.